FAQ/Help |
Calendar |
Search |
Today's Posts |
10-01-2006, 10:08 AM | #1 | |||
|
||||
Senior Member
|
For people who are avoiding dbs and looking for a treatment that may provide neuroregeneration -- watch for the upcoming the CERE-120 phase II gene therapy multi-center trial coming later this fall of 2006.
They use neurturin -- a neurotrophic factor. Phase I safety trial was a success, and details will be published soon. ceregene press releases about phase I pdf presentation of phase I study design jean |
|||
Reply With Quote |
10-01-2006, 05:04 PM | #2 | ||
|
|||
Member
|
Phase 1 was a success ?
Aftermathman. |
||
Reply With Quote |
10-01-2006, 10:17 PM | #3 | |||
|
||||
Senior Member
|
Yes it was a success - I dialed in for an FDA webcast where ceregene presented results of phase I and also generally outlined their plans for phase II. Full details of the Phase I trial will be published (or presented - can't remember which) this month - October 2007. It sounds very promising.
Jean |
|||
Reply With Quote |
10-01-2006, 10:23 PM | #4 | |||
|
||||
Senior Member
|
Neither the webcast nor the minutes are linked yet - but i think they will be eventually. The meeting took place 9/20/06
This link goes to the web page where you will (eventually) see the link to the webcast about cere-120 phase I and plans for phase II. Jean |
|||
Reply With Quote |
10-02-2006, 01:58 AM | #5 | ||
|
|||
Member
|
for a good start to my day.
Aftermathman |
||
Reply With Quote |
10-02-2006, 03:25 AM | #6 | ||
|
|||
In Remembrance
|
Removed as author was worried about accuracy or misinterpretation, but do try to watch it when it comes online- it was quite interesting watching the questioning and defending of this trial. The trial has champions; wheras the Amgen champion of GNDF passed away of a heart attack. Watching this made me wonder how well it was defended.
paula Last edited by paula_w; 10-02-2006 at 07:56 AM. |
||
Reply With Quote |
10-02-2006, 09:26 AM | #7 | |||
|
||||
Senior Member
|
Cere-120 gives me hope for a neurorestorative treatment.
Yes, it's truly a pity about GDNF (which we're still fighting for). But hopefully cere-120 (neurturen) will fill that void for most of us. Jean |
|||
Reply With Quote |
Reply |
|
|